Our findings that hyperprolactinaemia is associated with reduced BMD in schizophrenia provides additional support and impetus for the inclusion of regular PRL monitoring in guidelines for physical health monitoring in those with schizophrenia. This evidence concerns the gene PRL and hyperpituitarism.